Boehringer Ingelheim Prescription Medicines - Effective primary and specialist care worldwide
These medicinal products require prescription either by primary care physicians or by specialists or form an integral part of hospital treatment. Branded Prescription Medicines, which represents the bulk of our Human Pharmaceuticals business, accounts for 79 % of our total net sales and generated in 2008 EUR 9,111 million (in local currencies).
Indication areas
Boehringer Ingelheim's product portfolio covers the following main indications:
- Acute Coronary Disease
- Benign Prostatic Hyperplasia
- Chronic Obstructive Pulmonary Disease (COPD)
- HIV/AIDS
- Hypertension
- Major Depressive Disorder (MDD)
- Parkinson's Disease
- Restless Legs Syndrome
- Stroke
- Thromboembolic Diseases
Other Indications
Just to mention a few of our other indications:
- generalised anxiety disorder
- diabetic peripheral neuropathic pain (DPNP)
- acute ischaemic stroke
